BioSante Pharmaceuticals Receives Two New Patents for Manufacture of ... EON: Enhanced Online News (press release) No., 7,632,059, covers methods for manufacturing recombinant antibodies. By incorporating our 2A/Furin technology into antibody-expression in viral vectors it is possible to rapidly generate stable, high producing antibody cell lines. The subsequent ... |
